Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial-Reference-Cited by-同舟云学术

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Published:2021-04 Issue:4 Volume:22 Page:450-462
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Lee Nancy Y,Ferris Robert L,Psyrri Amanda,Haddad Robert I,Tahara Makoto,Bourhis Jean,Harrington Kevin,Chang Peter Mu-Hsin,Lin Jin-Ching,Razaq Mohammad Abdul,Teixeira Maria Margarida,Lövey József,Chamois Jerome,Rueda Antonio,Hu Chaosu,Dunn Lara A,Dvorkin Mikhail Vladimirovich,De Beukelaer Steven,Pavlov Dmitri,Thurm Holger,Cohen Ezra

Funder

Pfizer

Merck KGaA

Publisher

Elsevier BV

Subject

Oncology

Reference26 articles.

1. Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors;Braakhuis;Ann Oncol,2012

2. Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review;Winquist;J Otolaryngol Head Neck Surg,2017

3. Multidisciplinary management of locally advanced SCCHN: optimizing treatment outcomes;Ang;Oncologist,2008

4. Head and neck cancer;Chow;N Engl J Med,2020

5. Human papillomavirus and survival of patients with oropharyngeal cancer;Ang;N Engl J Med,2010

Cited by 362 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy in Head and Neck Cancer;Surgical Oncology Clinics of North America;2024-10

2. Recurrent Versus Metastatic Head and Neck Cancer: An Evolving Landscape and the Role of Immunotherapy;Biomedicines;2024-09-12

3. Immunological signatures from irradiated cancer-associated fibroblasts;Frontiers in Immunology;2024-09-06

4. A comprehensive and longitudinal evaluation of the different populations of lymphoid and myeloid cells in the peripheral blood of patients treated with chemoradiotherapy for head and neck cancer;Cancer Immunology, Immunotherapy;2024-09-05

5. Parameters to assess the necessity of adjuvant therapy for early‐stage oral squamous cell carcinoma;Oral Diseases;2024-09-03